Benitec Biopharma Limited
Company Overview
Benitec Biopharma Limited is a biotechnology company focused on the development of novel genetic medicines. The company utilizes its proprietary DNA-directed RNA interference (ddRNAi) technology platform to develop treatments for genetic disorders. Their lead product candidate is BB-301, designed to treat Oculopharyngeal Muscular Dystrophy (OPMD), a rare genetic condition.
The company is currently in the clinical development phase and does not generate revenue from product sales. Their operations primarily consist of research and development activities.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Benitec Biopharma Limited's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.